1Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma [ J ]. Lancet, 003,362(9399) :1907-1917.
2Iizuka N, Hamamoto Y, Tsunedomi R, et al. Translational microarray systems for outcome prediction of hepatocellular carcinoma [ J ]. Cancer Sci, 2008,99(4) :659-665.
3Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma [ J]. N Engl J Med, 2008,359(19) :1995-2004.
4Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning [ J ]. Nat Med, 2003,9 (4) :416-423.
5Okamoto M, Utsunomiya T, Wakiyama S, et al. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C viruspositive patients [J]. Ann Surg Oncol, 2006,13 (7) :947-954.
6Iizuka N, Oka M, Yamada-Okabe H, et al. Oligonueleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection [ J ]. Lancet, 2003,361 (9361) :923-929.
7Kurokawa Y, Matoba R, Takemasa I, et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma [ J]. J Hepatol, 2004,41 (2) :284-291.
8Ho MC, Lin JJ, Chen CN, et al. A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach [ J ]. Ann Surg Oncol, 2006,13 ( 11 ) : 1474-1484.
9Somura H, Iizuka N, Tamesa T, et al. A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy [ J ]. Oncol Rep, 2008,19 (2) :489-495.
10Budhu A, Forgues M, Ye QH, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment [J]. Cancer Cell, 2006,10(2) :99-111.
